KHK's pharma sales up 58% in 1st-half 2009

Japanese firm Kyowa Hakko Kirin says its total revenue jumped 29% year-on-year to 247.77 billion yen ($2.5 billion) for the first half of fiscal 2009, on additional turnover from the recent acquisition of Kirin Pharma (Marketletter October 29, 2007).

Pharmaceutical sales reached 108.7 billion yen, a jump of 58%. However, 4.7 billion yen of costs associated with the merger cut net income by 25% to 8.29 billion yen, despite an upfront payment received from Amgen on the completion of a licensing agreement.